Minicircle DNA Vectors for Non-Integrating Stem Cell Reprogramming

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for generating induced pluripotent stem cells (iPS cells) face challenges such as low reprogramming efficiency and undesirable genomic modifications using integrating viral vectors, necessitating the development of higher efficiency methods that do not permanently alter the cell genome.

Innovation Solution

The use of minicircle DNA vectors encoding reprogramming factors, such as Oct4, Sox2, Lin28, and Nanog, to induce pluripotency in somatic cells, which are maintained in culture to reprogram them into iPS cells, offering a non-integrating and efficient approach without genomic modification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If integrating viral vectors are used to deliver reprogramming factors, then reprogramming efficiency is improved, but genomic modification occurs which is undesirable

Engineering Contradiction:

Improvereprogramming efficiencyVSAvoidgenomic modification

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent segments the viral vector system into separate functional components: the reprogramming factors are delivered via viral vectors while the genomic integration step is eliminated. This allows high-efficiency delivery without permanent genomic modification, resolving the contradiction between productivity and harmful effects.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent employs transient expression of reprogramming factors followed by their removal from the system. The factors are delivered efficiently via viral vectors but are not permanently integrated, allowing the cells to be recovered in a transgene-free state, thus achieving both high efficiency and genomic stability.

Inventive Principle:

Principle #34Discarding and recovering

2Reliability

If traditional reprogramming methods are used, then pluripotent stem cells are generated, but the process is time-consuming and has low efficiency

Engineering Contradiction:

Improvepluripotency inductionVSAvoidreprogramming duration

Core Design Contradiction:

ReliabilityVSLoss of time

Solution Approach 1:

The patent performs preliminary optimization of reprogramming factor combinations and delivery methods before actual reprogramming. By pre-establishing optimal conditions including factor dosages and timing, the actual reprogramming process is accelerated while maintaining high reliability of pluripotency induction.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent maintains continuous expression of reprogramming factors throughout the reprogramming process through optimized delivery systems and culture conditions. This continuous action ensures reliable pluripotency induction while reducing the overall time required compared to intermittent or stepwise approaches.

Inventive Principle:

Principle #20Continuity of useful action

Data Source

PatentUS8962331B2Method of making induced pluripotent stem cell from adipose stem cells using minicircle DNA vectors

Publication Date: 2015.02.24 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

AI summary

Human somatic cells are reprogrammed to become induced pluripotent stem cells (iPS cells) by the introduction of a minicircle DNA vector. Cells of interest include adipose stem cells.